Drug-Resistant Fungus Spreads
Drug-resistant fungus Candida auris continues to spread across US, impacting vulnerable patients
A drug-resistant fungus called Candida auris is spreading across the United States, with 3,437 clinical cases documented this year across 27 states, according to Orlando Sentinel. The pathogen is nicknamed a "superbug" because it resists most anti-fungal medications, making infections extremely hard to treat.
The fungus was first discovered in 2009, and U.S. clinical cases began appearing in 2016. Since then, case counts have risen every single year. In 2024 alone, there were 6,304 new clinical cases nationwide, according to Sun Sentinel.
Who Is Most at Risk From Candida Auris
Most healthy people have little to fear. Dr. Ulysses Wu, an infectious disease specialist with Hartford HealthCare, says the fungus mostly targets patients who are already very sick. People with severe underlying medical conditions are the primary group at risk, according to Delco Times.
Patients who rely on invasive medical devices face the highest danger. That includes breathing tubes, feeding tubes, and catheters. These devices give the fungus a way to enter the body. Patients in intensive care units are especially vulnerable, Press Enterprise reported.
Colonization vs. Infection: A Key Distinction
Doctors stress an important difference between being "colonized" by the fungus and actually being infected. Colonization means the fungus lives on a person's skin or body without causing illness. A true clinical infection means the fungus has entered the bloodstream or organs, which can be life-threatening, according to Pilot Online.
This distinction matters for how hospitals respond. A colonized patient may not need treatment but still requires isolation to stop the fungus from spreading to others. A patient with a true infection needs aggressive antifungal therapy, OC Register reported.
Case Growth Is Slowing, But Spread Continues
The number of U.S. cases has climbed every year since 2016. However, Greeley Tribune noted that the rate of increase has been slowing in recent years. That is a cautiously positive sign, though experts say the fungus is still actively spreading into new states.
The fungus has now been found in 27 states. It spreads easily in healthcare settings. It can survive on surfaces and skin for weeks. Standard hospital disinfectants often fail to kill it, making outbreak control extremely difficult, according to San Diego Union-Tribune.
Why Candida Auris Is So Difficult to Treat
Candida auris resists most of the drugs doctors use to fight fungal infections. Many strains are resistant to all three main classes of antifungal medication. This leaves doctors with few treatment options for severely ill patients, News-Herald reported.
The CDC has listed Candida auris as an urgent public health threat. Early detection is critical. Hospitals in affected states are being urged to screen high-risk patients and strengthen infection control practices, according to Trentonian.
Sentiment
NeutralPublishers
13
Articles
12
Reach
13
